Cover Image


Dual Chamber Syringes & Injectors to 2022

出版商 Greystone Research Associates 商品編碼 281703
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
雙腔室注射器&注射器:設備、治療方法、市場、預測 Dual Chamber Syringes & Injectors to 2022
出版日期: 2015年09月01日 內容資訊: 英文




  • 設備的演進
  • 處方因素
  • 產品固有辦法的開發
  • 特殊注射設備需求的促進要素
    • 慢性疾病及自我施打
    • 生技藥品的成長
    • 處方及投藥
    • 患者統計的變化
    • 藥物的經濟學、安全性及遵守
    • 設備設計及創新
  • 競爭情形
  • 技術市場促進要素


  • 墨盒
  • 注射器
  • 注射器


  • 產品固有的辦法
  • 特殊設備
  • OEM設備


  • 血糖管理
  • 遺傳性疾病
  • 荷爾蒙補充
  • 感染疾病
  • 代謝性疾病
  • 腫瘤
  • 生殖健康
  • 其他治療領域


  • 設備產品策略
  • 設備的經濟學
  • 產品品牌策略
  • 直銷行銷
  • 管理護理、醫療經濟



Product Code: DCJ222R

Innovative Devices for Drug Reconstitution

In terms of formulation market share gains, lyophilized injectable drugs are the fastest growing drug formulation segment. From 1990 to 1998 the share of newly approved lyophilized drugs as a share of all injectable/infusible drugs was 11.9%. In 2011, it was 41% and in 2013, injectable/infusible drugs requiring reconstitution made up half of all new approvals. Because a significant number of these drugs are developed for self-administration, they present special challenges for developers. Dual chamber injection devices - designed to simplify reconstitution without patient handling of drug or diluent - have become the mainstay delivery option for this class of drugs. As lyophilized injectables continue to increase in number and market share, dual chamber syringes and injectors will experience double-digit annual unit growth.

The value we provide to our clients and subscribers is best illustrated by our ability to consistently provide strategic direction and market knowledge that contributes to their tactical and strategic decision process.

What You Will Learn

  • What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
  • What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
  • What are the key dual chamber device selection factors, technologies and market development issues?
  • What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2022?
  • What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
  • How important are pharma-device alliances and design partnerships on dual chamber injection devices?
  • What is the impact of economic, technology, and regulatory factors?

Tailored Research

As technology and products evolve, the level of precision in management decisions required to enable effective company performance is increasing. Such precision cannot be achieved without timely and accurate data about the company's macroscopic operating environment. The information that you and your management team require to execute your business and market strategies is unique to your organization and business model. This is why - in addition to the multi-client reports you will find on our site - we offer client-specific research services that start with customer-defined needs and culminate in assessments and analysis that answer the questions that represent risk to your business strategy. To discuss Greystone's Customer Defined Research services, we invite you to contact us.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

In the past two decades, drug delivery has become a major factor in the advancement of the quality of life and a key factor in the business success of pharmaceutical companies. During this time, syringes and injectors have evolved considerably to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling.

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • Evolution in Device Design
  • Formulation Factors
  • Product Specific Device Development
  • Specialty Injection Device Demand Drivers
    • Chronic Conditions and Self-Administration
    • The Growth of Biologicals
    • Formulation and Dosing
    • Shifting Patient Demographics
    • Drug Economics, Safety and Compliance
    • Device Design and Innovation
  • Competitive Landscape
  • Technology Market Drivers

The Dual Chamber Injection Device Ecosystem

  • Dual Chamber Cartridges
  • Dual Chamber Injectors
  • Dual Chamber Syringes

Dual Chamber Syringe & Injector Device Assessments

  • Product-Specific Devices
  • Specialty Devices
  • OEM Devices

Therapeutic Segments - Market Data & Forecasts

  • Glycemic Control
  • Hereditary Conditions
  • Hormone Replacement
  • Infectious Disease
  • Metabolic Conditions
  • Oncology
  • Reproductive Health
  • Other Therapeutic Segments

Market Factors

  • Device Product Strategies
  • Device Economics
  • Product Branding
  • Direct-to-Consumer Marketing
  • Managed Care Trends

Company Profiles

Back to Top